# Characterising Shared and Specific Cell–Cell Communication in Cardiomyopathy Subtypes From Single‐Cell Transcriptomics Data

## TL;DR

This paper explores how different types of heart disease affect cell communication, revealing both shared and unique patterns that could help develop better treatments.

## Contribution

The study identifies universal and subtype-specific intercellular communication patterns in cardiomyopathy using single-cell RNA sequencing data.

## Key findings

- Inflammatory, autoimmune, and fibrotic processes are common across all cardiomyopathy subtypes.
- Each cardiomyopathy subtype has distinct communication patterns, such as arrhythmia in ACM and ECM remodelling in HCM.
- Ischemic injury and recovery pathways are uniquely active in ischemic cardiomyopathy.

## Abstract

Cardiomyopathy encompasses a diverse range of conditions characterised by extensive molecular heterogeneity, particularly the variations in cell–cell communication events such as ligand‐receptor interactions and downstream signalling. Understanding the common and unique features of these intercellular interactions is crucial for advancing targeted treatments. We analysed single‐cell RNA sequencing datasets from the ventricular regions of patients with arrhythmogenic cardiomyopathy (ACM), dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM) and healthy donors (HD), as well as ischemic cardiomyopathy (ICM). Our analyses focused on cell type‐specific disease preferences, differential gene expression, pathway enrichment and particularly cell–cell communication. We observed that inflammatory, autoimmune, angiogenesis, lymphangiogenesis and fibrotic extracellular matrix deposition are consistently enriched across all four disease subtypes, highlighting their universal significance in disease progression through intercellular interactions. Additionally, we identified subtype‐specific pathways that reflect distinct intercellular communication patterns unique to each disease subtype: arrhythmia‐associated pathways in ACM, chronic inflammation‐related pathways in DCM, ECM remodelling pathways in HCM and ischaemic injury and recovery pathways in ICM.